Topical application of colchicine, vinblastine and vincristine prevents strychnine-enhanced transsynaptic degeneration in the medullary dorsal horn following transection of the inferior alveolar nerve in adult rats

Tomosada Sugimoto, Motohide Takemura, Akira Sakai, Masashi Ishimaru

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The effect of topical application of axonal transport blockers to the transected peripheral nerve was assessed by quantitating the strychnine-enhanced transsynaptic degeneration following transection of the inferior alveolar nerve in adult rats. Systemic administration of strychnine (1 mg/kg/day) for 7 days at the postoperational interval of 23 days proved to be suitable for quantitating the transsynaptic degeneration at the light microscopic level. When the proximal stump of transected nerve was treated with 2% colchicine immediately after transection, 5.8 ± 6.8 dark neurons in a single section of the medullary dorsal horn, ipsilateral to the nerve transection, were observed. Following similar treatment with 0.4% vinblastine and 0.2% vincristine, 24.4 ± 10.5 and 9.4 ± 7.0 dark neurons were seen, respectively. When compared with 43.0 ± 9.4 dark neurons, which were seen in animals without alkaloid treatment, colchicine, vinblastine and vincristine significantly reduced the transsynaptic degeneration by 86, 43, and 78%, respectively. Possible mechanisms involved in prevention of transsynaptic degeneration by the alkaloids are discussed.

Original languageEnglish
Pages (from-to)91-100
Number of pages10
JournalPain
Volume27
Issue number1
DOIs
Publication statusPublished - 1986
Externally publishedYes

Fingerprint

Mandibular Nerve
Strychnine
Vinblastine
Colchicine
Vincristine
Neurons
Alkaloids
Axonal Transport
Peripheral Nerves
Light
Spinal Cord Dorsal Horn

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Neuroscience(all)
  • Neurology
  • Pharmacology
  • Clinical Psychology

Cite this

Topical application of colchicine, vinblastine and vincristine prevents strychnine-enhanced transsynaptic degeneration in the medullary dorsal horn following transection of the inferior alveolar nerve in adult rats. / Sugimoto, Tomosada; Takemura, Motohide; Sakai, Akira; Ishimaru, Masashi.

In: Pain, Vol. 27, No. 1, 1986, p. 91-100.

Research output: Contribution to journalArticle

@article{59283f7c7c4f418ebd8f7203dc47c956,
title = "Topical application of colchicine, vinblastine and vincristine prevents strychnine-enhanced transsynaptic degeneration in the medullary dorsal horn following transection of the inferior alveolar nerve in adult rats",
abstract = "The effect of topical application of axonal transport blockers to the transected peripheral nerve was assessed by quantitating the strychnine-enhanced transsynaptic degeneration following transection of the inferior alveolar nerve in adult rats. Systemic administration of strychnine (1 mg/kg/day) for 7 days at the postoperational interval of 23 days proved to be suitable for quantitating the transsynaptic degeneration at the light microscopic level. When the proximal stump of transected nerve was treated with 2{\%} colchicine immediately after transection, 5.8 ± 6.8 dark neurons in a single section of the medullary dorsal horn, ipsilateral to the nerve transection, were observed. Following similar treatment with 0.4{\%} vinblastine and 0.2{\%} vincristine, 24.4 ± 10.5 and 9.4 ± 7.0 dark neurons were seen, respectively. When compared with 43.0 ± 9.4 dark neurons, which were seen in animals without alkaloid treatment, colchicine, vinblastine and vincristine significantly reduced the transsynaptic degeneration by 86, 43, and 78{\%}, respectively. Possible mechanisms involved in prevention of transsynaptic degeneration by the alkaloids are discussed.",
author = "Tomosada Sugimoto and Motohide Takemura and Akira Sakai and Masashi Ishimaru",
year = "1986",
doi = "10.1016/0304-3959(86)90226-5",
language = "English",
volume = "27",
pages = "91--100",
journal = "Pain",
issn = "0304-3959",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Topical application of colchicine, vinblastine and vincristine prevents strychnine-enhanced transsynaptic degeneration in the medullary dorsal horn following transection of the inferior alveolar nerve in adult rats

AU - Sugimoto, Tomosada

AU - Takemura, Motohide

AU - Sakai, Akira

AU - Ishimaru, Masashi

PY - 1986

Y1 - 1986

N2 - The effect of topical application of axonal transport blockers to the transected peripheral nerve was assessed by quantitating the strychnine-enhanced transsynaptic degeneration following transection of the inferior alveolar nerve in adult rats. Systemic administration of strychnine (1 mg/kg/day) for 7 days at the postoperational interval of 23 days proved to be suitable for quantitating the transsynaptic degeneration at the light microscopic level. When the proximal stump of transected nerve was treated with 2% colchicine immediately after transection, 5.8 ± 6.8 dark neurons in a single section of the medullary dorsal horn, ipsilateral to the nerve transection, were observed. Following similar treatment with 0.4% vinblastine and 0.2% vincristine, 24.4 ± 10.5 and 9.4 ± 7.0 dark neurons were seen, respectively. When compared with 43.0 ± 9.4 dark neurons, which were seen in animals without alkaloid treatment, colchicine, vinblastine and vincristine significantly reduced the transsynaptic degeneration by 86, 43, and 78%, respectively. Possible mechanisms involved in prevention of transsynaptic degeneration by the alkaloids are discussed.

AB - The effect of topical application of axonal transport blockers to the transected peripheral nerve was assessed by quantitating the strychnine-enhanced transsynaptic degeneration following transection of the inferior alveolar nerve in adult rats. Systemic administration of strychnine (1 mg/kg/day) for 7 days at the postoperational interval of 23 days proved to be suitable for quantitating the transsynaptic degeneration at the light microscopic level. When the proximal stump of transected nerve was treated with 2% colchicine immediately after transection, 5.8 ± 6.8 dark neurons in a single section of the medullary dorsal horn, ipsilateral to the nerve transection, were observed. Following similar treatment with 0.4% vinblastine and 0.2% vincristine, 24.4 ± 10.5 and 9.4 ± 7.0 dark neurons were seen, respectively. When compared with 43.0 ± 9.4 dark neurons, which were seen in animals without alkaloid treatment, colchicine, vinblastine and vincristine significantly reduced the transsynaptic degeneration by 86, 43, and 78%, respectively. Possible mechanisms involved in prevention of transsynaptic degeneration by the alkaloids are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0022513916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022513916&partnerID=8YFLogxK

U2 - 10.1016/0304-3959(86)90226-5

DO - 10.1016/0304-3959(86)90226-5

M3 - Article

C2 - 3785967

AN - SCOPUS:0022513916

VL - 27

SP - 91

EP - 100

JO - Pain

JF - Pain

SN - 0304-3959

IS - 1

ER -